{
    "visits": [
        {
            "title": "Up to 15 weeks, including ≥2 IVIg cycles",
            "notes": "",
            "type": "In Person",
            "timing": "'Fixed Reference Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "PT0M",
            "activities": [
                {
                    "title": "Informed consent",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Medical history",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Demography",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Inclusion/exclusion criteria check",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EQ-5D-5L",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "RT-FSS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SF-12",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "INCAT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "FSH test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Physical examination",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Weight measurement",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SIB risk monitoring",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Clinical laboratory testing, including urinalysis",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for SLE panel",
                    "procedures": [
                        "If the ANA result is ≥1:80",
                        "titer and staining patterns will be reported",
                        "If anti-Smith and/or anti-double-stranded DNA tests are positive",
                        "the presence of antiphospholipid antibodies (anticardiolipin and anti-beta-2-glycoprotein) will be determined"
                    ],
                    "notes": ""
                },
                {
                    "title": "Samples for immunogenicity",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for virology screen",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for encapsulated bacteria antibody titers",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Research sample",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "Up to 15 weeks, including ≥2 IVIg cycles",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "PT0M",
            "activities": [
                {
                    "title": "Inclusion/exclusion criteria check",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "Up to 15 weeks, including ≥2 IVIg cycles",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "PT0M",
            "activities": [
                {
                    "title": "Inclusion/exclusion criteria check",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SIB risk monitoring",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Clinical laboratory testing, including urinalysis",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "1d",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "P1D",
            "activities": [
                {
                    "title": "Randomization",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Inclusion/exclusion criteria check",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EQ-5D-5L",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "RT-FSS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SF-12",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "INCAT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "TSQM-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Physical examination",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Weight measurement",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SIB risk monitoring",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Clinical laboratory testing, including urinalysis",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for SLE panel",
                    "procedures": [
                        "If the ANA result is ≥1:80",
                        "titer and staining patterns will be reported",
                        "If anti-Smith and/or anti-double-stranded DNA tests are positive",
                        "the presence of antiphospholipid antibodies (anticardiolipin and anti-beta-2-glycoprotein) will be determined"
                    ],
                    "notes": ""
                },
                {
                    "title": "Samples for PD",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for PK",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pharmacogenetic sample",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for complement factors",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for NfL",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for antiganglioside autoantibody titers",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for functional complement activity (CH50)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for immunogenicity",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for encapsulated bacteria antibody titers",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Research sample",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EMPA/EMPA-PBO administration",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg/IVIg-PBO administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "8",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "P8D",
            "activities": [
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-C",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SIB risk monitoring",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Clinical laboratory testing, including urinalysis",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for PD",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for PK",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for immunogenicity",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Research sample",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EMPA/EMPA-PBO administration",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg/IVIg-PBO administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "29",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "P29D",
            "activities": [
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EQ-5D-5L",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "RT-FSS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-C",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SF-12",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "INCAT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "TSQM-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SIB risk monitoring",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Clinical laboratory testing, including urinalysis",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for PD",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for PK",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for complement factors",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for NfL",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for functional complement activity (CH50)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for immunogenicity",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Research sample",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EMPA/EMPA-PBO administration",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg/IVIg-PBO administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "57",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "P57D",
            "activities": [
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-C",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EMPA/EMPA-PBO administration",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg/IVIg-PBO administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "85",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "P85D",
            "activities": [
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EQ-5D-5L",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "RT-FSS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-C",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SF-12",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "INCAT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "TSQM-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Weight measurement",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SIB risk monitoring",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Clinical laboratory testing, including urinalysis",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for SLE panel",
                    "procedures": [
                        "If the ANA result is ≥1:80",
                        "titer and staining patterns will be reported",
                        "If anti-Smith and/or anti-double-stranded DNA tests are positive",
                        "the presence of antiphospholipid antibodies (anticardiolipin and anti-beta-2-glycoprotein) will be determined"
                    ],
                    "notes": ""
                },
                {
                    "title": "Samples for PD",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for PK",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for complement factors",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for NfL",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for functional complement activity (CH50)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for immunogenicity",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Research sample",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EMPA/EMPA-PBO administration",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg/IVIg-PBO administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "113",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "P113D",
            "activities": [
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-C",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EMPA/EMPA-PBO administration",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg/IVIg-PBO administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "141",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "P141D",
            "activities": [
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-C",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EMPA/EMPA-PBO administration",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "IVIg/IVIg-PBO administration",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "169",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "P169D",
            "activities": [
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EQ-5D-5L",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "RT-FSS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-C",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SF-12",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "INCAT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "TSQM-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Exit interview",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Physical examination",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SIB risk monitoring",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Clinical laboratory testing, including urinalysis",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for SLE panel",
                    "procedures": [
                        "If the ANA result is ≥1:80",
                        "titer and staining patterns will be reported",
                        "If anti-Smith and/or anti-double-stranded DNA tests are positive",
                        "the presence of antiphospholipid antibodies (anticardiolipin and anti-beta-2-glycoprotein) will be determined"
                    ],
                    "notes": ""
                },
                {
                    "title": "Samples for PD",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for PK",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for complement factors",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for NfL",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for antiganglioside autoantibody titers",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for functional complement activity (CH50)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for immunogenicity",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for encapsulated bacteria antibody titers",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Research sample",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                }
            ]
        },
        {
            "title": "",
            "notes": "",
            "type": "In Person",
            "timing": "'After Timing Type'  'Up to 15 weeks, including ≥2 IVIg cycles'  'Start to Start'",
            "duration": "PT0M",
            "activities": [
                {
                    "title": "Grip strength",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "MMN-RODS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "mMRC-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "9-HPT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "EQ-5D-5L",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "CAP-PRI",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "RT-FSS",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-S",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "PGI-C",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SF-12",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "INCAT",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "TSQM-14",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pregnancy test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "FSH test",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Physical examination",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Weight measurement",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Vital sign measurements",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "12-lead ECG(s)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "SIB risk monitoring",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Clinical laboratory testing, including urinalysis",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for SLE panel",
                    "procedures": [
                        "If the ANA result is ≥1:80",
                        "titer and staining patterns will be reported",
                        "If anti-Smith and/or anti-double-stranded DNA tests are positive",
                        "the presence of antiphospholipid antibodies (anticardiolipin and anti-beta-2-glycoprotein) will be determined"
                    ],
                    "notes": ""
                },
                {
                    "title": "Samples for PD",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for PK",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Pharmacogenetic sample",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for complement factors",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for NfL",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for antiganglioside autoantibody titers",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for functional complement activity (CH50)",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for immunogenicity",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for virology screen",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Samples for encapsulated bacteria antibody titers",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Research sample",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Concomitant medication/procedures",
                    "procedures": [],
                    "notes": ""
                },
                {
                    "title": "Adverse events",
                    "procedures": [],
                    "notes": ""
                }
            ]
        }
    ]
}